The LEOSS registry aims to provide physicians and scientists with a reliable database on which to build decisions. The overriding goal is to provide optimal treatment for COVID-19 patients, especially those with a severe course of the disease.
"Our board of directors, the scientific committees and the general assembly of the DZHK agree that we should participate in important national and international activities in the coronavirus pandemic," says DZHK board chairman Professor Thomas Eschenhagen. At national level, the DZHK and the other German Centres for Health Research (DZG) are already coordinating their activities as closely as possible.
Further participants welcome
The German Society for Infectiology initiated LEOSS together with the German Centre for Infection Research (DZIF), the Emerging Infections Task Force of ESCMID supports the project. According to coordinator Professor Jörg Janne Vehreschild, DZIF scientist at the University Hospital of Cologne, the project also aims to collect clinical data from patients who are no longer able to consent. At LEOSS, this is made possible by strictly anonymous documentation of all patients with multi-level safety functions.
The register publishes all collected data and makes them available to the scientific community for joint analysis. It is multilingual and will be used throughout the EU. A special feature is the self-administration of the study by the participating centres.
Interested study centres and data analysts are invited to participate in LEOSS. Thus, the DZHK also encourages its clinical member institutions to participate in the register. Further information as well as the possibility for registration and participation can be found at https://leoss.net.
Source: https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients
Europe-wide register for SARS-CoV-2 infected patients